Hyperkalemia Risk Varies by Antihypertensive Combo for Diabe

Investigators assessed hyperkalemia risk with combined use of RAASi (ACEi, ARB, MRA, renin inhibitors) and SGLT2i to treat diabetic kidney disease.

Related Keywords

United States , Changzheng , Hainan , China , Shanghai , American , Zhiguo Mao , Second Military Medical University , Changzheng Hospital , Clinical Journal , American Society ,